|
ZNF714 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.922200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.666080E-02 |
| Normal-vs-Stage2 |
9.972800E-01 |
| Normal-vs-Stage3 |
4.117000E-01 |
| Normal-vs-Stage4 |
5.335000E-01 |
| Stage1-vs-Stage2 |
2.917200E-01 |
| Stage1-vs-Stage3 |
7.572100E-02 |
| Stage1-vs-Stage4 |
5.671000E-01 |
| Stage2-vs-Stage3 |
5.439600E-01 |
| Stage2-vs-Stage4 |
6.737200E-01 |
| Stage3-vs-Stage4 |
3.993400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.747600E-02 |
| Normal-vs-AfricanAmerican |
3.859400E-01 |
| Normal-vs-Asian |
9.981400E-01 |
| Caucasian-vs-AfricanAmerican |
5.570400E-01 |
| Caucasian-vs-Asian |
6.476800E-01 |
| AfricanAmerican-vs-Asian |
7.451200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.256400E-03 |
| Normal-vs-Female |
4.702800E-01 |
| Male-vs-Female |
6.820300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.274400E-01 |
| Normal-vs-Extreme_Weight |
2.040000E-02 |
| Normal-vs-Obese |
8.783600E-01 |
| Normal-vs-Extreme_Obese |
9.857800E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.165200E-01 |
| Normal_Weight-vs-Obese |
5.093400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.074200E-01 |
| Extreme_Weight-vs-Obese |
6.717500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.514400E-01 |
| Obese-vs-Extreme_Obese |
2.508300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.784000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.680000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.799800E-02 |
| Normal-vs-Age(81-100Yrs) |
2.027500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.698170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.579670E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.231660E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.847000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.566200E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.877000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.862900E-03 |
| Normal-VS-Type2 PRCC |
2.851400E-01 |
| Normal-VS-KIRP CIMP |
4.381400E-01 |
| Normal-VS-Unclassified PRCC |
2.247200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.607800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.754600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.202400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.627960E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.653600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.670400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.292000E-01 |
| Normal-vs-N1 |
2.134000E-01 |
| Normal-vs-N2 |
3.912300E-02 |
| N0-vs-N1 |
5.363600E-02 |
| N0-vs-N2 |
5.753800E-01 |
| N1-vs-N2 |
1.953770E-01 |
|
|
